Tissue-type plasminogen activator should not be used in acute ischemic stroke.
Riggs
J E
JE
Department of Neurology, West Virginia University School of Medicine, Morgantown, USA.
D000208:Acute Disease; D002543:Cerebral Hemorrhage / Q000209:etiology; D002561:Cerebrovascular Disorders / Q000188:drug therapy* / Q000209:etiology; D002986:Clinical Trials as Topic; D000075202:Contraindications; D003657:Decision Making; D005060:Europe; D006801:Humans; D002546:Ischemic Attack, Transient / Q000150:complications / Q000188:drug therapy*; D009316:National Institutes of Health (U.S.); D010960:Plasminogen Activators / Q000627:therapeutic use*; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*; D014481:United States
D010960:Plasminogen Activators; D010959:Tissue Plasminogen Activator